Ryan CJ - Search Results

1

Quo vadis: advanced prostate cancer-clinical care and clinical research in the era of multiple androgen receptor-directed therapies.

Kim W, Ryan CJ. Kim W, et al. Among authors: ryan cj. Cancer. 2015 Feb 1;121(3):361-71. doi: 10.1002/cncr.28929. Epub 2014 Sep 18. Cancer. 2015. PMID: 25236176 Free article. Review.

2

Advances in prostate cancer.

Ryan CJ, Small EJ. Ryan CJ, et al. Curr Opin Oncol. 2004 May;16(3):242-6. doi: 10.1097/00001622-200405000-00009. Curr Opin Oncol. 2004. PMID: 15069320 Review.

3

Secondary hormonal manipulations in prostate cancer.

Ryan CJ, Small EJ. Ryan CJ, et al. Curr Oncol Rep. 2005 May;7(3):228-33. doi: 10.1007/s11912-005-0078-x. Curr Oncol Rep. 2005. PMID: 15847715 Review.

4

Early versus delayed androgen deprivation for prostate cancer: new fuel for an old debate.

Ryan CJ, Small EJ. Ryan CJ, et al. J Clin Oncol. 2005 Nov 10;23(32):8225-31. doi: 10.1200/JCO.2005.03.5311. J Clin Oncol. 2005. PMID: 16278477 Review.

5

Chemotherapy for hormone-refractory prostate cancer: now it's a question of "when?".

Ryan CJ, Eisenberger M. Ryan CJ, et al. J Clin Oncol. 2005 Nov 10;23(32):8242-6. doi: 10.1200/JCO.2005.03.3092. J Clin Oncol. 2005. PMID: 16278479 Review.

6

Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: scientific rationale and study design.

Beekman KW, Colevas AD, Cooney K, Dipaola R, Dunn RL, Gross M, Keller ET, Pienta KJ, Ryan CJ, Smith D, Hussain M. Beekman KW, et al. Among authors: ryan cj. Clin Genitourin Cancer. 2006 Mar;4(4):299-302. doi: 10.3816/CGC.2006.n.012. Clin Genitourin Cancer. 2006. PMID: 16729916

7

Secondary hormonal manipulations in prostate cancer.

Ryan CJ. Ryan CJ. Hematol Oncol Clin North Am. 2006 Aug;20(4):925-34. doi: 10.1016/j.hoc.2006.03.005. Hematol Oncol Clin North Am. 2006. PMID: 16861123 Review.

8

The case for secondary hormonal therapies in the chemotherapy age.

Small EJ, Ryan CJ. Small EJ, et al. Among authors: ryan cj. J Urol. 2006 Dec;176(6 Pt 2):S66-71. doi: 10.1016/j.juro.2006.06.071. J Urol. 2006. PMID: 17084172 Review.

9

Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.

Ryan CJ, Haqq CM, Simko J, Nonaka DF, Chan JM, Weinberg V, Small EJ, Goldfine ID. Ryan CJ, et al. Urol Oncol. 2007 Mar-Apr;25(2):134-40. doi: 10.1016/j.urolonc.2006.07.019. Urol Oncol. 2007. PMID: 17349528

10

Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study.

Ryan CJ, Halabi S, Ou SS, Vogelzang NJ, Kantoff P, Small EJ. Ryan CJ, et al. Clin Cancer Res. 2007 Apr 1;13(7):2030-7. doi: 10.1158/1078-0432.CCR-06-2344. Clin Cancer Res. 2007. PMID: 17404083 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

478 results

Search Page

Filters